Page 5 - Department Of Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Department of pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Department Of Pharma Today - Breaking & Trending Today

16.5L vials of Remdesivir allocated to states from May 3-9: Govt

16.5L vials of Remdesivir allocated to states from May 3-9: Govt
By
IANS
|
4 Views
Two male nurses held for selling Remdesivir. Image Source: IANS News
New Delhi, May 5 : Union Minister of Chemicals & Fertilisers, D.V. Sadananda Gowda, on Wednesday reviewed the availability of drugs for Covid treatment and other essential medicines.
Gowda said that 16.5 lakh vials of Remdesivir have been allocated to all the states between May 3 and May 9, adding that since April 21, a total allocation of 34.5 lakh vials has been made to the states.
Allocation to the states is a dynamic process and efforts will be made to further enhance supply in the coming weeks, he said. ....

New Delhi , Dv Sadananda Gowda , Department Of Pharma , Ministry Of Health Family Welfare , Union Minister , Drugs Controller General , Family Welfare , புதியது டெல்ஹி , ட்வ் சதானந்த கவுடா , துறை ஆஃப் பார்மா , அமைச்சகம் ஆஃப் ஆரோக்கியம் குடும்பம் நலன்புரி , தொழிற்சங்கம் அமைச்சர் , மருந்துகள் கட்டுப்படுத்தி ஜநரல் , குடும்பம் நலன்புரி ,

Daily new cases continue to plateau in 12 States: Health Ministry

Daily new cases continue to plateau in 12 States: Health Ministry
May 05, 2021
Inter-ministerial panel looking at deployment of aid received from foreign countries, says official
There continues to be a plateauing in daily Covid-19 cases in 12 States in the last 14 days, Health Ministry data showed. These States are Maharashtra, Uttar Pradesh, Delhi, Chhattisgarh, Gujarat, Madhya Pradesh, Telangana, Jharkhand, Daman & Diu, Ladakh, Lakshadweep and Andaman & Nikobar. However, Health Ministry official Lav Agarwal said this is not the time to loosen up seeing the early decline as it may cost dearly to the country, going forward.
“In the case of infections, even a single day laxity may squander the efforts made to come to a low level of Coronavirus cases. That’s why there is a need to make continuous efforts towards containing the further spread,” said Agarwal, who is a Joint Secretary in the Health Ministry. ....

Jammu And Kashmir , Uttar Pradesh , Madhya Pradesh , Tamil Nadu , Andhra Pradesh , Sadananda Gowda , Daman Diu , National Pharmaceutical Pricing Authority , Department Of Pharma , Health Ministry , Central Drugs Standard Control Organisation , Lav Agarwal , Joint Secretary , West Bengal , Union Minister , Fertilisers Sadananda Gowda , State Drug Controllers , ஜம்மு மற்றும் காஷ்மீர் , உத்தர் பிரதேஷ் , மத்யா பிரதேஷ் , தமிழ் நாடு , ஆந்திரா பிரதேஷ் , சதானந்த கவுடா , தமன் துீஉ , தேசிய மருந்து ப்ரைஸிஂக் அதிகாரம் , துறை ஆஃப் பார்மா ,

Remdesivir output to be ramped up as Covid-19 cases rise sharply

Drug majors are stepping on the gas to produce more doses of key antiviral drug remdesivir as India witnesses a new peak in daily Covid-19 cases.
At least four companies Hetero, Cadila Healthcare (Zydus Cadila), Mylan, and Cipla confirmed to Business Standard that they are working to raise production of this drug soon.
Pankaj Patel, chairman of Zydus Cadila, said they were planning to double their production of remdesivir from 30,000 vials daily. “In the next few weeks, we will double the current production. We are making 30,000 vials daily now. The demand for the drug is on the rise and we are doing our best to ensure there is no supply shortage,” Patel said. ....

Pankaj Patel , Zydus Cadila , Kedar Upadhye , Department Of Pharma , Maharashtra Health Mi , National Pharmaceutical Pricing Auth , Cadila Healthcare , Rajesh Tope , பங்கஜ் படேல் , ஜய்துச் காடிலா , கெதர் உபபதியே , துறை ஆஃப் பார்மா , மகாராஷ்டிரா ஆரோக்கியம் மை , தேசிய மருந்து ப்ரைஸிஂக் அங்கீகாரம் , காடிலா சுகாதாரம் , ராஜேஷ் தோப்பே ,

Union Chemicals & Fertilizers Minister inaugurates a four day Global Investors meet: India Pharma 2021 & India Medical Devices 2021

Apr 5, 2021
Speaking on the occasion Shri DV Sadananda Gowda commended India’s capabilities as a global and reliable supplier of drugs and medical devices during the COVID-19 pandemic. Citing the recent UNCTAD report, he also pointed out India’s positive FDI growth even with a decline in FDI of 42% globally. Shri Gowda said, “As the pandemic exposed the global vulnerabilities of the supply chains in the pharmaceuticals sector, the Department of Pharmaceuticals launched the Production Linked Incentive Scheme for bulk drugs, with a financial outlay of ₹6,940 crores across 53 APIs over 6 years. For Medical Devices, another PLI scheme was announced with an outlay of ₹3,420. Such interventions & incentives have played an instrumental role in realizing Prime Minister’s vision of ‘Aatmanirbhar Bharat’, or India for the world.” ....

New Delhi , Shri Piyush Goyal , Shri Mandaviya , Atmanirbhar Bharat , Shri Mansukhl Mandaviya , Aatmanirbhar Bharat , Shri Gowdafurther , Shri Gowda , Shri Dv Sadananda Gowda , Department Of Pharma , Glenmark Pharmaceuticals , Ministry Of Chemicals , Ministry Of Chemicals Fertilizers , Department Of Pharmaceuticals , Ministry Of Commerce , Pharma Bureau , Laurus Labs , Programme Of The Year Award , Union Chemicals , Wrignanosystems Private , Consumer Affairs , Global Investors , India Pharma , Medical Devices , Public Distribution Shri Piyush Goyal , Indian Pharmaceutical Industry ,